Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy

International Journal of Urology

Volumn 16, Issue 6, 2009, Pages 584-586

  Leonardo, Costantino ^a   Simone, Giuseppe ^b   Papalia, Rocco ^b   Franco, Giorgio ^a   Guaglianone, Salvatore ^b   Gallucci, Michele ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Prostate cancer; Radiation therapy; Radical prostatectomy; Salvage surgery

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MALE; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECTUM FISTULA; URETER CATHETERIZATION; URETHRA STRICTURE; URINE INCONTINENCE;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 66949166387     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02209.x     Document Type: Article

References (15)

1. Kuban DA, Thames HD, Levy LB et al. Long-term multi-institutional analysis of stage t1-t2 prostate cancer treated with radiotherapy in the PSA era. Int. J. Radiat. Oncol. Biol. Phys. 2003 57 : 915 28.
2. Lee WR, Hanks GE, Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J. Clin. Oncol. 1997 15 : 230 8.
3. Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: Data from cancer of the prostate strategic urologic research endeavor. J. Urol. 2002 168 : 530 5.
4. Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy: The message conveyed by serum prostate-specific antigen. Int. J. Radiat. Oncol. Biol. Phys. 1995 33 : 23 35.
5. Stephenson AJ, Scardino PT, Bianco FJ, Di Blasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcome of salvage RP for locally recurrent prostate cancer after radiation therapy. J. Urol. 2004 172 : 2239 43.
6. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT, Salvage RP. outcome measured by serum prostate-specific antigen levels. J. Urol. 1995 153 : 104 10.
7. Lerner SE, Blute ML, Zincke H. Critical evaluation of salvage surgery for radio-recurrent-resistant prostate cancer. J. Urol. 1995 154 : 1103 9.
8. Rigaud J, Tiguert R, Fradet Y, Bouchot O. Salvage RP after radiotherapy failure in localized prostatic cancer. Prog. Urol. 2002 12 : 1179 87.
9. Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zincke P. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J. Urol. 1999 161 : 857 62.
10. Schellhammer PF, Kuban DA, El-Mahdi AM. Treatment of clinical local failure after radiation therapy for prostate carcinoma. J. Urol. 1993 150 : 1851 5.
11. Holzman M, Carlton CE, Scardino PT. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J. Urol. 1991 146 : 1578 82.
12. Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Prospective assessment of patient reported urinary continence after radical prostatectomy. J. Urol. 2000 164 : 744 8.
13. Leibovich BC, Zincke H, Blute ML et al. Recurrent prostate cancer after radiation therapy: Salvage prostatectomy versus salvage cryosurgery. J Urol. 2001 165 (Suppl 389 abstract 1595.
14. Sanderson KM, Penson DF, Cai J et al. Salvage radical prostatectomy: Quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J. Urol. 2006 176 : 2025 32.
15. Ward JF, Sebo TJ, Blute ML, Zincke H. Salvage surgery for radiorecurrent prostate cancer: Contemporary outcomes. J. Urol. 2005 173 : 1156 60.